Topical Preparation of Pomegranate and Ginkgo Biloba for Anti-aging Activities

Ahmed A. H. Abdellatif

Status and phase: Unknown; Phase 1

Conditions: Skin and Subcutaneous Tissue Disorders

Treatments: Drug: Pomegrante and Ginkgo biloba group; Drug: Cream Base

Study type: Interventional

Funder types: Other

Identifiers

NCT03772418

AlAzharPGB

Details and patient eligibility

About

As the quality of life improves, people are seeking to look as young as they feel. Ginkgo biloba (GB) and Pomegranate (PG) extract can be used to create efficacious topical anti-aging products. GB & PG are now widely used in research and clinical trials on age-associated diseases, for example, skin aging, brain dysfunction, cardiovascular system diseases, carcinogen metabolism. The investigator's aim is to formulate a topical cream in the form (O/W or W/O emulsion) formulation, containing GB as an anti-aging formulation for the public.

Full description

In this study, a vanishing cream will be prepared by reaction of a stearic acid with alkali (NaOH) to form stearate soap. Then the GB extract will be added to the final form. The formulated cream will be characterized for identifying the type of emulsion, calibration curve for GB, drug content, irritation to skin, homogeneity test, pH, FT-IR test, ex vivo studies, physical stability, and human application. Finally, a 9-questions questionnaire was published using Google forms for the human volunteers.

Enrollment: 30 estimated patients

Sex: All

Ages: 50 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of aging shape
• Follow up and collect data for a local and systemic activity of Ginkgo Biloba and Pomegranate
• The skin should be not injured as the cream can be easily applied
• Systemic oral capsule Ginkgo Biloba and Pomegranate can be also given to enhance the activity as anti-aging activity

Exclusion criteria

• Insulin-dependent diabetes
• Hypertension disease
• Skin wound

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

30 participants in 2 patient groups, including a placebo group

Cream base

Placebo Comparator group

Description:

A group of volunteers receiving placebo medications without natural extracts of ginkgo biloba and Pomegranate.

Treatment:

Drug: Cream Base

Pomegrante and Ginkgo biloba group

Active Comparator group

Description:

A group of volunteers with the aging state receiving natural extracts of ginkgo biloba and Pomegranate in different topical dosage forms.

Treatment:

Drug: Pomegrante and Ginkgo biloba group